litlas
Log inCreate account

Geoffrey Liu

Active 1984–2025

300
Papers
36,033
Citations
100
h-index
274
i10-index

Citations

Citations per year for Geoffrey Liu1958: 1 citations1984: 1 citations1985: 5 citations1986: 2 citations1987: 3 citations1988: 5 citations1989: 2 citations1990: 5 citations1991: 2 citations1992: 1 citations1993: 2 citations1994: 1 citations1995: 1 citations1996: 1 citations1997: 3 citations1998: 7 citations1999: 7 citations2000: 10 citations2001: 36 citations2002: 52 citations2003: 66 citations2004: 93 citations2005: 110 citations2006: 170 citations2007: 148 citations2008: 191 citations2009: 224 citations2010: 193 citations2011: 192 citations2012: 173 citations2013: 181 citations2014: 183 citations2015: 252 citations2016: 248 citations2017: 271 citations2018: 281 citations2019: 936 citations2020: 1,143 citations2021: 1,224 citations2022: 1,106 citations2023: 950 citations2024: 1,531 citations2025: 840 citations2026: 34 citations1959–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,738 citing papers, 22.1% of this breakdownChina: 2,603 citing papers, 15.4% of this breakdownUnited Kingdom: 1,056 citing papers, 6.2% of this breakdownCanada: 894 citing papers, 5.3% of this breakdownItaly: 753 citing papers, 4.5% of this breakdownGermany: 651 citing papers, 3.9% of this breakdownFrance: 567 citing papers, 3.4% of this breakdownSpain: 509 citing papers, 3% of this breakdownJapan: 492 citing papers, 2.9% of this breakdownNetherlands: 475 citing papers, 2.8% of this breakdownAustralia: 424 citing papers, 2.5% of this breakdownSouth Korea: 351 citing papers, 2.1% of this breakdown
0%22.1%Other 25.9%

Institutions

Fields

  • Medicine58.6%
  • Biochemistry, Genetics and Molecular Biology29.2%
  • Computer Science1.5%
  • Immunology and Microbiology1.4%
  • Neuroscience1.2%
  • Engineering1.1%
  • Other7%

Topics

  • Lung Cancer Treatments and Mutations8.5%
  • Lung Cancer Diagnosis and Treatment4.4%
  • Cancer Genomics and Diagnostics4.2%
  • Lung Cancer Research Studies3.7%
  • Cancer Immunotherapy and Biomarkers2.2%
  • RNA modifications and cancer1.8%
  • Other75.2%

Coauthors

All papers

Open in search
  1. First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer

    Authors: Alice T. Shaw, Todd M. Bauer, Filippo de Marinis, Enriqueta Felip, Yasushi Goto, Geoffrey Liu, Julien Mazières, Dong‐Wan Kim, Tony Mok, Anna Polli, Holger Thurm, Anna Maria Calella, Gerson Peltz, Benjamin Solomon - New England Journal of Medicine 2020 cited by 1,064

  2. Sensitive tumour detection and classification using plasma cell-free DNA methylomes

    Authors: Shu Yi Shen, Rajat Singhania, Gordon Fehringer, Ankur Chakravarthy, Michael H. A. Roehrl, Dianne Chadwick, Philip C. Zuzarte, Ayelet Borgida, Ting Ting Wang, Tiantian Li, Olena Kis, Zhen Zhao, Anna Spreafico, Tiago da Silva Medina, Yadon Wang, David Roulois, Ilias Ettayebi, Zhuo Chen, Signy Chow, Tracy Murphy, Andrea Arruda, Grainne M. O’Kane, Jessica Liu, Mark Mansour, John D. McPherson, Catherine O′Brien, Natasha B. Leighl, Philippe L. Bédard, Neil Fleshner, Geoffrey Liu, Mark D. Minden, Steven Gallinger, Anna Goldenberg, Trevor J. Pugh, Michael M. Hoffman, Scott V. Bratman, Rayjean J. Hung, Daniel D. De Carvalho - Nature 2018 cited by 1,040

  3. Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

    Authors: Annette McWilliams, Martin C. Tammemägi, John R. Mayo, Heidi Roberts, Geoffrey Liu, Kam Soghrati, Kazuhiro Yasufuku, Simon Martel, Francis Laberge, Michel Gingras, Sukhinder Atkar-Khattra, Christine D. Berg, Ken Evans, Richard J. Finley, John Yee, John C. English, Paola Nasute, John R. Goffin, Serge Puksa, Lori Stewart, Scott Tsai, Michael R. Johnston, Daria Manos, Garth Nicholas, Glenwood Goss, Jean M. Seely, Kayvan Amjadi, Alain Tremblay, Paul Burrowes, Paul MacEachern, Rick Bhatia, Ming‐Sound Tsao, Stephen Lam - New England Journal of Medicine 2013 cited by 1,404

  4. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

    Authors: James McKay, Rayjean J Hung, Younghun Han, Xuchen Zong, Robert Carreras‐Torres, David C. Christiani, Neil E. Caporaso, Mattias Johansson, Xiangjun Xiao, Yafang Li, Jinyoung Byun, Alison M. Dunning, Karen A. Pooley, David C. Qian, Xuemei Ji, Geoffrey Liu, Maria Timofeeva, Stig E. Bojesen, Xifeng Wu, Loı̈c Le Marchand, Demetrius Albanes, Heike Bickeböller, Melinda C. Aldrich, William S. Bush, Adonina Tardón, Gad Rennert, M. Dawn Teare, John K. Field, Lambertus A. Kiemeney, Philip Lazarus, Aage Haugen, Stephen Lam, Matthew B. Schabath, Angeline S. Andrew, Hongbing Shen, Yun‐Chul Hong, Jian‐Min Yuan, Pier Alberto Bertazzi, Angela Cecilia Pesatori, Yuanqing Ye, Nancy Diao, Li Su, Ruyang Zhang, Yonathan Brhane, Natasha B. Leighl, Jakob Sidenius Johansen, Anders Mellemgaard, Walid Saliba, Christopher A. Haiman, Lynne R. Wilkens, Ana Fernández‐Somoano, Guillermo Fernández‐Tardón, Erik H.F.M. van der Heijden, Jin Hee Kim, Juncheng Dai, Zhibin Hu, Michael P.A. Davies, Michael W. Marcus, Hans Brunnström, Jonas Manjer, Olle Melander, David C. Muller, Kim Overvad, Antonia Trichopoulou, ­Rosario ­Tumino, Jennifer A. Doherty, Matt P Barnett, Chu Chen, Gary E. Goodman, Angela Cox, Fiona Taylor, Penella J. Woll, Irene Brüske, H‐Erich Wichmann, Judith Manz, Thomas R Muley, Angela Risch, Albert Rosenberger, Kjell Grankvist, Mikael Johansson, Frances A. Shepherd, Ming‐Sound Tsao, Susanne M. Arnold, Eric B. Haura, Ciprian Bolca, Ivana Holcátová, Vladimí­r Janout, Milica Kontić, Jolanta Lissowska, Anush Mukeria, Simona Ognjanovic, Tadeusz Orłowski, Ghislaine Scélo, Beata Świątkowska, Давид Заридзе, Per Bakke, Vidar Skaug, Shanbeh Zienolddiny, Eric J. Duell, Lesley M. Butler and 40 more - Nature Genetics 2017 cited by 794

  5. Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study

    Authors: Benjamin Solomon, Todd M. Bauer, Tony Mok, Geoffrey Liu, Julien Mazières, Filippo de Marinis, Yasushi Goto, Dong‐Wan Kim, Yi‐Long Wu, Jacek Jassem, Froylán López López, Ross A. Soo, Alice T. Shaw, Anna Polli, Rossella Messina, Laura Iadeluca, Francesca Toffalorio, Enriqueta Felip - The Lancet Respiratory Medicine 2022 cited by 221

  6. Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study

    Authors: Benjamin Solomon, Geoffrey Liu, Enriqueta Felip, Tony Mok, Ross A. Soo, Julien Mazières, Alice T. Shaw, Filippo de Marinis, Yasushi Goto, Yi‐Long Wu, Dong‐Wan Kim, Jean-François Martini, Rossella Messina, Jolanda Paolini, Anna Polli, Despina Thomaidou, Francesca Toffalorio, Todd M. Bauer - Journal of Clinical Oncology 2024 cited by 313

  7. The adoption of artificial intelligence in employee recruitment: The influence of contextual factors

    Authors: Yuan Pan, Fabian Jintae Froese, Geoffrey Liu, Yunyang Hu, Maolin Ye - The International Journal of Human Resource Management 2021 cited by 353

  8. Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer

    Authors: Ruoshi Shi, Nikolina Radulovich, Christine Ng, Geoffrey Liu, Hirotsugu Notsuda, Michael Cabanero, Sebastião N. Martins-Filho, Vibha Raghavan, Quan Li, Arvind Singh Mer, Joshua C. Rosen, Ming Li, Yu-Hui Wang, Laura Tamblyn, Nhu‐An Pham, Benjamin Haibe‐Kains, Geoffrey Liu, Nadeem Moghal, Ming‐Sound Tsao - Clinical Cancer Research 2019 cited by 327

  9. Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy

    Authors: Masashi Mikubo, Yoshiaki Inoue, Geoffrey Liu, Ming‐Sound Tsao - Journal of Thoracic Oncology 2021 cited by 201

  10. First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study

    Authors: Siow Ming Lee, Christian Schulz, Kumar Prabhash, Dariusz M. Kowalski, Aleksandra Szczęsna, Baohui Han, Achim Rittmeyer, Toby Talbot, David Vicente, Raffaele Califano, Diego Cortinovis, Anh T. Le, Dingzhi Huang, Geoffrey Liu, Federico Cappuzzo, Jessica Reyes Contreras, Martin Reck, Ramón Palmero, Milena Perez Mak, Youyou Hu, Stefanie Morris, Elen Höglander, Mary M. Connors, Alice M. Biggane, Hans Kristian Moen Vollan, Solange Peters - The Lancet 2023 cited by 158

  11. Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

    Authors: Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons‐Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, M. Pérol, Céline Mascaux, Elena Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Min Hee Hong, Enriqueta Felip, Richard D. Hall, Óscar Juan, Daniel Brungs, Shun Lü, Marina Chiara Garassino, Michael Chargualaf, Yong Zhang, Paul Howarth, Deise Uema, Aaron Lisberg, Jacob Sands, for the TROPION-Lung01 Trial Investigators, Gastón Lucas Martinengo, Juan Puig, Daniel Brungs, Bo Gao, Adnan Nagria, Christos S. Karapetis, Sagun Parakh, Cheol Park, Gaëtan Catala, Frédéric Forget, Sebahat Ocak, Naveen S. Basappa, Geoffrey Liu, Ines B. Menjak, Benjamin Shieh, Shun Lü, Feng Luo, Hongmei Sun, Jialei Wang, Yu Yao, Milada Zemanová, Jaafar Bennouna, Nicolas Girard, Laurent Greillier, Corinne Lamour, H. Léna, Céline Mascaux, Julien Mazières, Denis Moro‐Sibilot, M. Pérol, Elvire Pons‐Tostivint, Virginie Westeel, Akin Atmaca, Christine Greil, Niels Reinmuth, Christian Schumann, Thomas Wehler, Juergen Wolf, James Ho, Csaba Böcskei, Federico Cappuzzo, Filippo de Marinis, Claudia Proto, Manlio Mencoboni, Silvia Novello, Stefania Salvagni, Héctor Soto Parrà, Haruko Daga, Yasushi Goto, Hidetoshi Hayashi, Satoru Kitazono, Kiyotaka Yoh, Ryo Ko, Masashi Kondo, Toshiyuki Kozuki, Takayasu Kurata, Hideaki Mizutani, Kadoaki Ohashi, Satoshi Oizumi, Isamu Okamoto, Satoshi Sakaguchi, H Ozasa, Shunichi Sugawara, Yuichi Tambo, Motohiro Tamiya, Hiroshi Tanaka, Isamu Okamoto, Froylán López-López, Francisco Javier Ramírez Godinez, Jerónimo Rafael Rodríguez Cid, Robin Cornelissen, Steven Gans and 61 more - Journal of Clinical Oncology 2024 cited by 182

  12. Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non–Small-Cell Lung Cancer From the Phase III CROWN Study

    Authors: Benjamin Solomon, Todd M. Bauer, Sai‐Hong Ignatius Ou, Geoffrey Liu, Hidetoshi Hayashi, Alessandra Bearz, Konstantin Penkov, Yi‐Long Wu, Óscar Arrieta, Jacek Jassem, Anna Maria Calella, Gerson Peltz, Anna Polli, Holger Thurm, Tony Mok - Journal of Clinical Oncology 2022 cited by 134

  13. Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study

    Authors: Lawson Eng, Rinku Sutradhar, Yue Niu, Ning Liu, Ying Liu, Yosuf Kaliwal, Melanie Powis, Geoffrey Liu, Jeffrey Peppercorn, Philippe L. Bédard, Monika K. Krzyzanowska - Journal of Clinical Oncology 2023 cited by 102

  14. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

    Authors: Alice T. Shaw, Tae Min Kim, Lucio Crinò, Cesare Gridelli, Katsuyuki Kiura, Geoffrey Liu, Silvia Novello, Alessandra Bearz, Oliver Gautschi, Tony Mok, Makoto Nishio, Giorgio V. Scagliotti, David R. Spigel, Stéphanie Deudon, Cheng Zheng, Serafino Pantano, Patrick Urban, Cristian Massacesi, Kalyanee Viraswami-Appanna, Enriqueta Felip - The Lancet Oncology 2017 cited by 580

  15. Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer

    Authors: Alice T. Shaw, Dong-Wan Kim, Ranee Mehra, Daniel S.W. Tan, Enriqueta Felip, Laura Q.M. Chow, D. Ross Camidge, Johan Vansteenkiste, Sunil Sharma, Tommaso De Pas, Gregory J. Riely, Benjamin Solomon, Juergen Wolf, Michael Thomas, Martin Schüler, Geoffrey Liu, Armando Santoro, Yvonne Lau, Meredith A. Goldwasser, Anthony Boral, Jeffrey A. Engelman - New England Journal of Medicine 2014 cited by 1,475

  16. Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients

    Authors: Sandy D. Der, Jenna Sykes, Melania Pintilie, Chang‐Qi Zhu, Dan Strumpf, Geoffrey Liu, Igor Jurišica, Frances A. Shepherd, Ming‐Sound Tsao - Journal of Thoracic Oncology 2013 cited by 404

  17. Automatic Recognition of Laryngoscopic Images Using a Deep‐Learning Technique

    Authors: Jianjun Ren, Xueping Jing, Jing Wang, Xue Ren, Xu Yang, Qiuyun Yang, Lanzhi Ma, Yi Sun, Wei Xu, Ning Yang, Jian Zou, Yongbo Zheng, Min Chen, Weigang Gan, Ting Xiang, Junnan An, Ruiqing Liu, Cao Lv, Ken Lin, Zheng Xianfeng, Fan Lou, Yufang Rao, Hui Yang, Kai Liu, Geoffrey Liu, Tao Lü, Xiujuan Zheng, Yu Zhao - The Laryngoscope 2020 cited by 142

  18. Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model

    Authors: Nadeem Moghal, Quan Li, Erin Stewart, Roya Navab, Masashi Mikubo, Elisa D’Arcangelo, Sebastião N. Martins-Filho, Vibha Raghavan, Nhu‐An Pham, Ming Li, Frances A. Shepherd, Geoffrey Liu, Ming‐Sound Tsao - Journal of Thoracic Oncology 2022 cited by 63

  19. Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer

    Authors: Chétana Lim, Ming‐Sound Tsao, Lisa W. Le, Frances A. Shepherd, Ronald Feld, R. Burkes, Geoffrey Liu, Suzanne Kamel‐Reid, D. Hwang, Jeffrey Tanguay, Gilda da Cunha Santos, Natasha B. Leighl - Annals of Oncology 2015 cited by 245

  20. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer

    Authors: Mark Gormley, Tom Dudding, Eleanor Sanderson, Richard M. Martin, Steven J. Thomas, Jessica Tyrrell, Andrew R. Ness, Paul Brennan, Marcus R. Munafò, Miranda Pring, Stefania Boccia, Andrew F. Olshan, Brenda Diergaarde, Rayjean J. Hung, Geoffrey Liu, George Davey Smith, Rebecca C. Richmond - Nature Communications 2020 cited by 143

  21. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

    Authors: Jinyoung Byun, Younghun Han, Yafang Li, Jun Xia, Erping Long, Jiyeon Choi, Xiangjun Xiao, Meng Zhu, Wen Zhou, Ryan Sun, Yohan Bossé, Zhuoyi Song, Ann G. Schwartz, Christine M. Lusk, Þórunn Rafnar, Kāri Stefánsson, Tongwu Zhang, Zhao Wei, Rowland W. Pettit, Yanhong Liu, Xihao Li, Hufeng Zhou, Kyle M. Walsh, Ivan P. Gorlov, Olga Y. Gorlova, Dakai Zhu, Susan M. Rosenberg, Susan M. Pinney, Joan E. Bailey‐Wilson, Diptasri Mandal, Mariza de Andrade, Colette Gaba, James C. Willey, Ming You, Marshall W. Anderson, John K. Wiencke, Demetrius Albanes, Stephan Lam, Adonina Tardón, Chu Chen, Gary E. Goodman, Stig Bojeson, Hermann Brenner, Maria Teresa Landi, Stephen J. Chanock, Mattias Johansson, Thomas Muley, Angela Risch, H.‐Erich Wichmann, Heike Bickeböller, David C. Christiani, Gad Rennert, Susanne M. Arnold, John K. Field, Sanjay Shete, Loı̈c Le Marchand, Olle Melander, Hans Brunnström, Geoffrey Liu, Angeline S. Andrew, Lambertus A. Kiemeney, Hongbing Shen, Shanbeh Zienolddiny, Kjell Grankvist, Mikael Johansson, Neil E. Caporaso, Angela Cox, Yun‐Chul Hong, Jian‐Min Yuan, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Alpa V. Patel, Qing Lan, Nathaniel Rothman, Fiona Taylor, Linda Kachuri, John S. Witte, Lori C. Sakoda, Margaret R. Spitz, Paul Brennan, Xihong Lin, James McKay, Rayjean J. Hung, Christopher I. Amos - Nature Genetics 2022 cited by 121

  22. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    Authors: Yufei Wang, James McKay, Þórunn Rafnar, Zhaoming Wang, Maria Timofeeva, Peter Broderick, Xuchen Zong, Marina Laplana, Yongyue Wei, Younghun Han, Amy Lloyd, Manon Delahaye-Sourdeix, Daniel Chubb, Valérie Gaborieau, William Wheeler, Nilanjan Chatterjee, Guðmar Þorleifsson, Patrick Sulem, Geoffrey Liu, Rudolf Kaaks, Marc Henrion, Ben Kinnersley, Maxime Vallée, Florence Le Calvez‐Kelm, Victoria L. Stevens, Susan M. Gapstur, Wei V. Chen, Давид Заридзе, Neonilia Szeszenia‐Dabrowska, Jolanta Lissowska, Péter Rudnai, Eleonóra Fabiánová, Dana Mateș, Vladimír Bencko, Lenka Foretová, Vladimí­r Janout, Hans E. Krokan, Maiken E. Gabrielsen, Frank Skorpen, Lars J. Vatten, Inger Njølstad, Chu Chen, Gary E. Goodman, Simone Benhamou, Tõnu Vooder, Kristjan Välk, Mari Nelis, Andres Metspalu, Marcin Lener, Jan Lubiński, Mattias Johansson, Paolo Vineis, Antonio Agudo, Françoise Clavel‐Chapelon, H. Bas Bueno‐de‐Mesquita, Dimitrios Trichopoulos, Kay‐Tee Khaw, Mikael Johansson, Elisabete Weiderpass, Anne Tjønneland, Elio Ríboli, Mark Lathrop, Ghislaine Scélo, Demetrius Albanes, Neil E. Caporaso, Yuanqing Ye, Jian Gu, Xifeng Wu, Margaret R. Spitz, Hendrik Dienemann, Albert Rosenberger, Li Su, Athena Matakidou, Timothy Eisen, Kāri Stefánsson, Angela Risch, Stephen J. Chanock, David C. Christiani, Rayjean J Hung, Paul Brennan, Maria Teresa Landi, Richard S. Houlston, Christopher I. Amos - Nature Genetics 2014 cited by 481

  23. Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer

    Authors: Miguel García-Pardo, Kasia Czarnecka‐Kujawa, Jennifer Law, Alexandra Salvarrey, Roxanne Fernandes, Zhen Jason Fan, Thomas K. Waddell, Kazuhiro Yasufuku, Geoffrey Liu, Laura Donahoe, Andrew Pierre, Lisa W. Le, Tharsiga Gunasegaran, Noor Ghumman, Frances A. Shepherd, Penelope A. Bradbury, Adrian G. Sacher, Sabine Schmid, Lucy Corke, Jamie Feng, Tracy Stockley, Prodipto Pal, Patrik Rogalla, Christodoulos Pipinikas, Karen Howarth, Bana Ambasager, Laura Mezquita, Ming‐Sound Tsao, Natasha B. Leighl - JAMA Network Open 2023 cited by 61

  24. Using LeDock as a docking tool for computational drug design

    Authors: Geoffrey Liu, Zhibin Xu - IOP Conference Series Earth and Environmental Science 2019 cited by 94